Myristoylcarnitine
|
Basic information |
| Metabolite name | Myristoylcarnitine |
 | HMDB0254979 |
 |
N/A |
 |
6426854 |
| Synonyms | (±)-Myristoylcarnitine; |
| No. of studies | 1 |
|
Basic information |
| Metabolite name | Myristoylcarnitine |
| HMDB0254979 |
|
N/A |
|
6426854 |
| Synonyms | (±)-Myristoylcarnitine; |
| No. of studies | 1 |
|
Relationship between Myristoylcarnitine and depression (count: 1) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1007 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M1007 | Type2 | CUMS + fluoxetine + bifid triple viable capsules group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M1007 | Type2 | CUMS + bifid triple viable capsules group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M1007 | Type2 | CUMS + fluoxetine group vs. CUMS group | Serum | Sprague-Dawley rat | Down |